Selective targeting of α4β1 integrin attenuates murine graft versus host disease.
-
Authors
-
-
Alahmari, Bader1
-
Cooper, Matthew L1
-
Vij, Kiran1
-
Ritchey, Julie1
-
Ruminski, Peter1
-
Gao, Feng2
-
Choi, Jaebok3
-
DiPersio, John F4
-
1
Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
-
2
Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, 63110, USA.
-
3
Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA. [email protected]
-
4
Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA. [email protected]
- Type
- Published Article
- Journal
-
Leukemia
- Publisher
-
Springer Nature
- Publication Date
-
Nov 01, 2020
- Volume
-
34
- Issue
-
11
- Pages
-
3100–3104
- Identifiers
-
DOI: 10.1038/s41375-020-0786-0
-
PMID: 32152466
- Source
-
Medline
- Language
-
English
- License
-
Unknown
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 11/12/2020 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/32152466
